Metraipolis › archive › dc_7bda5031cd52

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults… — Europe PMC PMID:42245229

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42245229
DOI: 10.1093/ofid/ofag282
License (as archived): solo-consultazione
Archived: 2026-11-02T17:42:24.152Z
SHA-256 of the archived text: f89251d77e95c2b9e65251a99ad36950f5bd6ea242e79c89b1c67d0bfc1e97d5
Stable URL of this page: https://metraipolis.com/documento/dc_7bda5031cd52

How to cite

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults… — Europe PMC PMID:42245229 — Europe PMC (en), https://europepmc.org/article/MED/42245229 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bda5031cd52 (Metraipolis archive dc_7bda5031cd52, sha256 f89251d77e95c2b9e65251a99ad36950f5bd6ea242e79c89b1c67d0bfc1e97d5)

BibTeX

@misc{dc7bda5031cd52,
  title = {Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults… — Europe PMC PMID:42245229},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245229},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bda5031cd52; sha256 f89251d77e95c2b9e65251a99ad36950f5bd6ea242e79c89b1c67d0bfc1e97d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245229. Agents can read the archived copy with the MCP tool read_document.